238 related articles for article (PubMed ID: 31263279)
1. c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies.
Bernink JH; Ohne Y; Teunissen MBM; Wang J; Wu J; Krabbendam L; Guntermann C; Volckmann R; Koster J; van Tol S; Ramirez I; Shrestha Y; de Rie MA; Spits H; Romero Ros X; Humbles AA
Nat Immunol; 2019 Aug; 20(8):992-1003. PubMed ID: 31263279
[TBL] [Abstract][Full Text] [Related]
2. Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients.
Teunissen MBM; Munneke JM; Bernink JH; Spuls PI; Res PCM; Te Velde A; Cheuk S; Brouwer MWD; Menting SP; Eidsmo L; Spits H; Hazenberg MD; Mjösberg J
J Invest Dermatol; 2014 Sep; 134(9):2351-2360. PubMed ID: 24658504
[TBL] [Abstract][Full Text] [Related]
3. Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferation.
Ahn YO; Weeres MA; Neulen ML; Choi J; Kang SH; Heo DS; Bergerson R; Blazar BR; Miller JS; Verneris MR
Eur J Immunol; 2015 Aug; 45(8):2335-42. PubMed ID: 26046454
[TBL] [Abstract][Full Text] [Related]
4. Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice.
Montaldo E; Juelke K; Romagnani C
Eur J Immunol; 2015 Aug; 45(8):2171-82. PubMed ID: 26031799
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.
Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J
J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202
[TBL] [Abstract][Full Text] [Related]
6. Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis.
Villanova F; Flutter B; Tosi I; Grys K; Sreeneebus H; Perera GK; Chapman A; Smith CH; Di Meglio P; Nestle FO
J Invest Dermatol; 2014 Apr; 134(4):984-991. PubMed ID: 24352038
[TBL] [Abstract][Full Text] [Related]
7. Potential role of IL-17-producing CD4/CD8 double negative αβ T cells in psoriatic skin inflammation in a TPA-induced STAT3C transgenic mouse model.
Ueyama A; Imura C; Fusamae Y; Tsujii K; Furue Y; Aoki M; Suzuki M; Okuda T; Oshima I; Yasui K; Shichijo M; Yamamoto M
J Dermatol Sci; 2017 Jan; 85(1):27-35. PubMed ID: 27810232
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria.
Bernink JH; Krabbendam L; Germar K; de Jong E; Gronke K; Kofoed-Nielsen M; Munneke JM; Hazenberg MD; Villaudy J; Buskens CJ; Bemelman WA; Diefenbach A; Blom B; Spits H
Immunity; 2015 Jul; 43(1):146-60. PubMed ID: 26187413
[TBL] [Abstract][Full Text] [Related]
9. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin.
Bovenschen HJ; van de Kerkhof PC; van Erp PE; Woestenenk R; Joosten I; Koenen HJ
J Invest Dermatol; 2011 Sep; 131(9):1853-60. PubMed ID: 21654831
[TBL] [Abstract][Full Text] [Related]
10. ILC3-like ILC2 subset increases in minimal persistent inflammation after acute type II inflammation of allergic rhinitis and inhibited by Biminkang: Plasticity of ILC2 in minimal persistent inflammation.
Chen XJ; Liu C; Zhang S; Zhang LF; Meng W; Zhang X; Sun M; Zhang Y; Wang RZ; Yao CF
J Leukoc Biol; 2022 Dec; 112(6):1445-1455. PubMed ID: 36161355
[TBL] [Abstract][Full Text] [Related]
11. Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis.
Mashiko S; Bouguermouh S; Rubio M; Baba N; Bissonnette R; Sarfati M
J Allergy Clin Immunol; 2015 Aug; 136(2):351-9.e1. PubMed ID: 25792465
[TBL] [Abstract][Full Text] [Related]
12. A novel RORγt inhibitor is a potential therapeutic agent for the topical treatment of psoriasis with low risk of thymic aberrations.
Imura C; Ueyama A; Sasaki Y; Shimizu M; Furue Y; Tai N; Tsujii K; Katayama K; Okuno T; Shichijo M; Yasui K; Yamamoto M
J Dermatol Sci; 2019 Mar; 93(3):176-185. PubMed ID: 30905492
[TBL] [Abstract][Full Text] [Related]
13. Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin.
Dyring-Andersen B; Geisler C; Agerbeck C; Lauritsen JP; Gúdjonsdottir SD; Skov L; Bonefeld CM
Br J Dermatol; 2014 Mar; 170(3):609-16. PubMed ID: 24125475
[TBL] [Abstract][Full Text] [Related]
14. IL-17-Secreting γδ T Cells Are Completely Dependent upon CCR6 for Homing to Inflamed Skin.
Campbell JJ; Ebsworth K; Ertl LS; McMahon JP; Newland D; Wang Y; Liu S; Miao Z; Dang T; Zhang P; Charo IF; Singh R; Schall TJ
J Immunol; 2017 Nov; 199(9):3129-3136. PubMed ID: 28972090
[TBL] [Abstract][Full Text] [Related]
15. Innate Lymphoid Cells and Intestinal Inflammatory Disorders.
Zheng M; Zhu J
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163778
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity and diversity of group 3 innate lymphoid cells: new cells on the block.
Satoh-Takayama N
Int Immunol; 2016 Jan; 28(1):29-34. PubMed ID: 26462712
[TBL] [Abstract][Full Text] [Related]
17. TLR2-activated human langerhans cells promote Th17 polarization via IL-1beta, TGF-beta and IL-23.
Aliahmadi E; Gramlich R; Grützkau A; Hitzler M; Krüger M; Baumgrass R; Schreiner M; Wittig B; Wanner R; Peiser M
Eur J Immunol; 2009 May; 39(5):1221-30. PubMed ID: 19350551
[TBL] [Abstract][Full Text] [Related]
18. Skin-resident innate lymphoid cells converge on a pathogenic effector state.
Bielecki P; Riesenfeld SJ; Hütter JC; Torlai Triglia E; Kowalczyk MS; Ricardo-Gonzalez RR; Lian M; Amezcua Vesely MC; Kroehling L; Xu H; Slyper M; Muus C; Ludwig LS; Christian E; Tao L; Kedaigle AJ; Steach HR; York AG; Skadow MH; Yaghoubi P; Dionne D; Jarret A; McGee HM; Porter CBM; Licona-Limón P; Bailis W; Jackson R; Gagliani N; Gasteiger G; Locksley RM; Regev A; Flavell RA
Nature; 2021 Apr; 592(7852):128-132. PubMed ID: 33536623
[TBL] [Abstract][Full Text] [Related]
19. Plasticity and regulatory mechanisms of human ILC2 functions.
Maggi L; Capone M; Mazzoni A; Liotta F; Cosmi L; Annunziato F
Immunol Lett; 2020 Nov; 227():109-116. PubMed ID: 32822747
[TBL] [Abstract][Full Text] [Related]
20. Transcription Factor Bcl11b Controls Identity and Function of Mature Type 2 Innate Lymphoid Cells.
Califano D; Cho JJ; Uddin MN; Lorentsen KJ; Yang Q; Bhandoola A; Li H; Avram D
Immunity; 2015 Aug; 43(2):354-68. PubMed ID: 26231117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
